Martingale Asset Management L P Kempharm, Inc Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$4.02 - $5.21 $40 - $52	10 Added 0.01%	75,622 $337,000
Q1 2022 May 12, 2022	BUY	$5.0 - $9.26 $62,060 - $114,935	12,412 Added 19.64%	75,612 $380,000
Q4 2021 Feb 11, 2022	BUY	$7.6 - $10.26 $2,378 - $3,211	313 Added 0.5%	63,200 $550,000
Q3 2021 Nov 12, 2021	BUY	$8.72 - $13.31 $370,259 - $565,155	42,461 Added 207.88%	62,887 $586,000
Q2 2021 Aug 13, 2021	BUY	$8.52 - $15.47 $174,029 - $315,990	20,426 New	20,426 $261,000

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.